Methods to improve neural outcome

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6812208
APP PUB NO 20020035066A1
SERIAL NO

09866536

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for treatment or prophylaxis of a patient suffering from functional symptoms of Parkinson's disease, especially as a consequence of damage to dopaminergic neurons, by administering to the patient a neuroprotective amount of a peptide selected from the tripeptide gly-pro-glu (GPE) and analogs and mimetics thereof, preferably GPE. The GPE will usually be administered subsequent to the onset of Parkinson's disease but prior to the damage of said dopaminergic neurons.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUREN PHARMACEUTICALS LTDLEVEL 3 2-6 PARK AVENUE GRAFTON AUCKLAND

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gluckman, Peter D Auckland, NZ 9 60
Guan, Jian Auckland, NZ 36 153
Krishnamurthi, Rita V M Auckland, NZ 1 0
Williams, Christopher E Auckland, NZ 12 83

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation